Benefit-Risk Assessment [resa]
Class III antiarrhythmic agent [phsu]
Beta-Blockers [phsu]
exception [idcn]
Increasing [ftcn]
doubt [menp]
Value [qnco]
Antiarrhythmic drug [phsu]
therapy [ftcn]
Following [tmco]
Series [qnco]
Trial [resa]
Show [inpr]
Mortality [qnco]
Benefit [qnco]
Mortality, Excess [qnco]
Class I [clas]
Drugs [phsu]
Patients [podg]
Structural [spco]
Heart disease [dsyn]
Class IV [inpr]
Drugs [phsu]
Heart failure [dsyn]
Arrhythmias [patf]
Problem [fndg]
Increase [ftcn]
Incidence [qnco]
Atrial Fibrillation [patf]
Sudden death [patf]
Population [qnco]
Old [tmco]
More [ftcn]
Patients [podg]
SURVIVE [phsu]
Long [qlco]
Time period [tmco]
Congestive heart failure [dsyn]
Increase [ftcn]
frequency [qnco]
Ventricular arrhythmias [patf]
Class III antiarrhythmic drug [phsu]
ACT [topp]
Blocking [mobd]
currents [tmco]
Effective refractory period [lbtr]
Myocardium [tisu]
This [euka]
To [qlco]
Termination [inpr]
RE [idcn]
Entry [inpr]
Tachyarrhythmias [fndg]
This [euka]
Class [inpr]
Drugs [phsu]
treatment [ftcn]
Ventricular arrhythmias [patf]
Amiodarone [orch, phsu]
Sotalol [orch, phsu]
dofetilide [orch, phsu]
ibutilide [orch, phsu]
Example [cnce]
Class III [inpr]
Drugs [phsu]
Currently [tmco]
Available [ftcn]
Amiodarone [orch, phsu]
Sotalol [orch, phsu]
Anti-arrhythmic [phsu]
properties [qlco]
PurE [moft]
Class III [inpr]
Action [ftcn]
differentiate [qlco]
Others [fndg]
Potential [qlco]
Serious Adverse Event [fndg]
Torsade de Pointes [dsyn]
Common [qnco]
Problem [fndg]
Make [ftcn]
benefit risk [qlco]
Ratio [qnco]
Drugs [phsu]
Question [inpr]
Class III [inpr]
Drugs [phsu]
Evaluated [ftcn]
Different [qlco]
setting [ftcn]
Primary [qlco]
Secondary Prevention [topp]
Ventricular arrhythmias [patf]
In [qnco]
treatment [ftcn]
Atrial Fibrillation [patf]
flutter [patf]
Based [ftcn]
Evidence [ftcn]
Routine [qlco]
indication [idcn]
Antiarrhythmic drug [phsu]
therapy [ftcn]
Beta-Blockers [phsu]
Patients [podg]
High Risk [qlco]
Sudden death [patf]
subgroup [virs]
Analysis [lbpr]
Trial [resa]
Amiodarone [orch, phsu]
dofetilide [orch, phsu]
Suggest [idcn]
Patients [podg]
Atrial Fibrillation [patf]
Mortality [qnco]
reduction [npop]
Drugs [phsu]
Needs [qlco]
tested [inpr]
prospective [resa]
Trial [resa]
subgroups [virs]
Benefit [qnco]
Prophylactic treatment [topp]
Class III antiarrhythmic drug [phsu]
Found [qnco]
Based [ftcn]
QT interval [clna]
Future [tmco]
Genetic Testing [lbpr]
Class III [inpr]
Drugs [phsu]
effective [qlco]
Atrial Fibrillation [patf]
Sinus rhythm [fndg]
Maintenance [acty]
Sinus rhythm [fndg]
Conversion [ftcn]
This [euka]
Currently [tmco]
Most [qnco]
indication [idcn]
Class [inpr]
Drugs [phsu]
Defined [cnce]
Recent [tmco]
Guidelines [inpr]
Amiodarone [orch, phsu]
dofetilide [orch, phsu]
Place [spco]
Second Line Therapy [topp]
Patients [podg]
Heart failure [dsyn]
First-Line Therapy [topp]
Only [qnco]
Drugs [phsu]
Safety [hcpp]
Documented [hlca]
Group [idcn]
High Risk [qlco]
Patients [podg]
